Myocardial perfusion pressure in patients with hypertension and coronary artery disease: Implications for DBP targets in hypertension management

Journal of Hypertension

Volumn 31, Issue 5, 2013, Pages 975-982

  Rabkin, Simon W ^a   Waheed, Aiza ^a   Poulter, Rohan S ^a   Wood, David ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

coronary artery disease; diabetes mellitus; fractional flow reserve; hypertension; target blood pressure

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; FEMALE; HEART MUSCLE PERFUSION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 84876292853     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32835e831c     Document Type: Article

References (43)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
2. Rabkin SW, Mathewson AL, Tate RB. Predicting risk of ischemic heart disease and cerebrovascular disease from systolic and diastolic blood pressures. Ann Intern Med 1978; 88:342-345.
3. Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL Jr, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Preventi. Circulation 2007; 115:2761-2788.
4. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caul-field MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27:2121-2158.
5. Daskalopoulou SS, Khan NA, Quinn RR, Ruzicka M, McKay DW, Hackam DG, Rabkin SW. The 2012 Canadian Hypertension Education Program (CHEP) recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk and therapy. Can J Cardiol 2012; 28:270-287.
6. Drozda J Jr, Messer JV, Spertus J, et al. ACCF/AHA/AMA-PCPI 2011 Performance Measures for Adults With Coronary Artery Disease and Hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association. Circulation 2011; 124:248-270.
7. Anderson TW. Re-examination of some of the Framingham blood-pressure data. Lancet 1978; 2:1139-1141.
8. Stewart IM. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet 1979; 1:861-865.
9. Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet 1987; 1:581-584.
10. Cruickshank JM. Blood pressure and myocardial infarction. Low blood pressure can be hazardous. BMJ 1994; 308:1301-1302.
11. Cruickshank JM. Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. BMJ 1988; 297:1227-1230.
12. D'Agostino RB, Belanger AJ, Kannel WB, Cruickshank JM. Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study. BMJ 1991; 303:385-389.
13. Messerli FH, Panjrath GS. The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential? J Am Coll Cardiol 2009; 54:1827-1834.
14. Messerli FH, Mancia G, Conti CR, Hewkin AC, Kupfer S, Champion A, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 2006; 144:884-893.
15. Chrysant SG, Chrysant GS. Effectiveness of lowering blood pressure to prevent stroke versus to prevent coronary events. Am J Cardiol 2010; 106:825-829.
16. Bangalore S, Qin J, Sloan S, Murphy SA, Cannon CP. What is the optimal blood pressure in patients after acute coronary syndromes? Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TI). Circulation 2010; 122:2142-2151.
17. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
18. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial, HOT Study Group. Lancet 1998; 351:1755-1762.
19. ACCORD Study, Cushman WC, Evans GW, Byington RP, Goff Jr DC, Grimm Jr RH, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362:1575-1585.
20. Cruickshank JM. Clinical importance of coronary perfusion pressure in the hypertensive patient with left ventricular hypertrophy. Cardiology 1992; 81:283-290.
21. Feigl EO, Neat GW, Huang AH. Interrelations between coronary artery pressure, myocardial metabolism and coronary blood flow. J Mol Cell Cardiol 1990; 22:375-390.
22. Mosher P, Ross J Jr, Mcfate PA, Shaw RF. Control of coronary blood flow by an autoregulatory mechanism. Circ Res 1964; 14:250-259.
23. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993; 87:1354-1367.
24. Kern MJ, de Bruyne B, Pijls NH. From research to clinical practice: current role of intracoronary physiologically based decision making in the cardiac catheterization laboratory. J Am Coll Cardiol 1997; 30:613-620.
25. Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek J, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996; 334:1703-1708.
26. Pijls NH, Sels JW. Functional measurement of coronary stenosis. J Am Coll Cardiol 2012; 59:1045-1057.
27. Hoole SP, Seddon MD, Poulter RS, Starovoytov A, Wood DA, Saw J. Development and validation of the fractional flow reserve (FFR) angiographic scoring tool (FAST) to improve the angiographic grading and selection of intermediate lesions that require FFR assessment. Coronary Artery Dis 2012; 23:45-50.
28. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van't Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009; 360:213-224.
29. De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino P, Piroth Z, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012; 367:991-1001.
30. Dole WP, Richards KL, Hartley CJ, Alexander GM, Campbell AB, Bishop VS. Diastolic coronary artery pressure-flow velocity relationships in conscious man. Cardiovasc Res 1984; 18:548-554.
31. Downey JM, Kirk ES. Inhibition of coronary blood flow by a vascular waterfall mechanism. Circ Res 1975; 36:753-760.
32. Messina LM, Hanley FL, Uhlig PN, Baer RW, Grattan MT, Hoffman JI. Effects of pressure gradients between branches of the left coronary artery on the pressure axis intercept and the shape of steady state circumflex pressure-flow relations in dogs. Circ Res 1985; 56:11-19.
33. Klocke FJ. Measurements of coronary flow reserve: defining patho-physiology versus making decisions about patient care. Circulation 1987; 76:1183-1189.
34. Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 2004; 292:2217-2225.
35. Fagard RH, Staessen JA, Thijs L, Celis H, Bulpitt CJ, De Leeuw PW, et al. On-treatment diastolic blood pressure and prognosis in systolic hypertension. Arch Intern Med 2007; 167:1884-1891.
36. de Bruyne B, Bartunek J, Sys SU, Sys SU, Pijlis NH, Heyndrickx GR, Wijns W. Simultaneous coronary pressure and flow velocity measurements in humans. Feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve. Circulation 1996; 94:1842-1849.
37. Tobis J, Azarbal B, Slavin L. Assessment of intermediate severity coronary lesions in the catheterization laboratory. J Am Coll Cardiol 2007; 49:839-848.
38. Cruickshank JM. The role of coronary perfusion pressure. Eur Heart J 1992; 13:39-43.
39. Kern MJ. An adenosine-independent index of stenosis severity from coronary wave-intensity analysis: a new paradigm in coronary physiology for the cath lab? J Am Coll Cardiol 2012; 59:1403-1405.
40. Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev 2008; 88:1009-1086.
41. Karamitsos TD, Leccisotti L, Arnold JR, Recio-Mayoral A, Bhamra-Ariza P, Howells RK, et al. Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography. Circ Cardiovasc Imag 2010; 3:32-40.
42. Kern MJ. Conversations in cardiology: using new media to transmit timely medical knowledge. How do you assess the left main stenosis with FFR and IVUS in a patient with multivessel CAD? Cath Cardiovasc Interven 2012; 80:465-471.
43. Leone AM, Porto I, De Caterina AR, Basile E, Aurelio A, Gardi A, et al. Maximal hyperemia in the assessment of fractional flow reserve: intra-coronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study. JACC Cardiovasc Interven 2012; 5:402-408.